Abstract
In the early days of hemodialysis efforts to treat and rehabilitate uremic diabetics were largely unsuccessful [1] until dialysis procedures and volume control had become more effective. Although diabetics have a poorer outcome than non-diabetics, survival has improved progressively, e.g. in the US adjusted first year mortality decreasing from 46% in 1982 to 30% in 1992 [2], although long-term survival is still very unsatisfactory, e.g. at 5 years 45% in type I and 10% in type II diabetics according to a recent German multicenter study [3]. Nevertheless it is no longer justified to deny admission to renal replacement therapy to the diabetic patient [4].
Keywords
- Diabetic Patient
- Renal Replacement Therapy
- Dialysis Patient
- Endstage Renal Failure
- Nephrol Dial Transplant
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Deceased October 14th, 1995
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ghavamian M, Gutch CG, Kopp KF, Kolff WJ. The sad truth about hemodialysis in diabetic nephropathy. JAMA 1972; 222:1386–1389
Brunner FP et al. Survival on renal replacement therapy: data from the EDTA registry. Nephrol Dial Transplant 1988; 1:109–122
Koch M, Kutkuhn B, Grabensee B, Ritz E. Apolipoprotein A, fibrinogen, age, and history of stroke are predictors of death in dialysed diabetic patients: a prospective study in 412 subjects. Nephrol Dial Transplant 1997; 12: 2603–2611
Pirson Y. The diabetic patient with ESRD: how to select the modality of renal replacement. Nephrol Dial Transplant 1996; 11:1511–1514
Annual Data Report. United States Renal Data System, April 1997
Lippert J, Ritz E, Schwarzbeck A, Schneider P. The rising tide of endstage renal faiulre from diabetic nephropathy type II — an epidemiological analysis. Nephrol Dial Transplant 1995; 10: 462–467
Raine AEG. Epidemiology, development and treatment of endstage renal failure in non-insulin dependent diabetics in Europe. Diabetologia 1993; 36:1099–1104
Rodriguez JA, Clèries M, Vela E and Renal Registry Committee. Diabetic patients on renal replacement therapy: anqalysis of Catalan Registry Data. Nephrol Dial Transplant 1997; 12: 2501–2509
Nineteenth Report of the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) 1996 (Disney APS, ed.)
Cordonnier DJ, Zmirou D, Benhamou PY, Halimi S, Ledoux F, Guiserix J. Epidemiology, development and treatment of endstage renal failure in Type 2 (non-insulin-dependent) diabetes. The case of mainland France and of overseas French territories. Diabetolgia 1993; 36:1109–1112
Cowie CC, Port FK, Wolfe RA, Savage PJ, Moll PP, Hawtome VM Disparities in incidence of diabetic end-stage renal disease according mto ravce and type of diabetes. N Engl J Med 1989; 321: 1074–1079
Ritz E, Nowack R, Fliser D, Koch M, Tschöpe W. Type II diabetes: Is the renal risk adequately appreciated? Nephrol Dial Transplant 1991; 6: 679–682
Catalano C, Postorino M, Kelly PJ, Fabrizi F, Emnia G, Goodship TH. Diabetes melliltus and renal replacement therapy in Italy: prevalence, main charcteristics and complications. Nephrol Dial Transplant 1990; 5:788–796
Ritz E, Strumpf C, Katz F, Wing AJ, Quellhorst E. Hypertension and cardiovascular risk factors in hemodialysed diabetic patients. Hypertension 1985; 7: 118–125
Koch M, Thomas B, Tschöpe W. Survival and predictors of death in dialysed diabetics. Diabetologia 1993; 36:1113–1117
Majorca R, et al. A six year comparison of patient and technique survivals in CAPD and HD. Kidney Int 1988; 34: 518–524
United States Renal Data System. Annual Data Report. Am J Kidn Dis 1991; 18: Suppl 2
Foley RN, Culleton BF, Parfrey PS, Harnett JD, Kent GM, Murray DC, Bare PE. Cardiac disease in diabetic endstage renal disease. Diabetologia 1997; 40: 1307–1312
Kikkawa A, Arimura T, Haneda M, Nkshio T, Katsunori S, Yagisawa M, Shigeta Y. Current status of type II (non-insulin-dependent) diabetic subjects on dialysis therapy in Japan. Diabetologia 1993; 36:1105–1108
Tschöpe W, Koch M, Thomas B, Ritz E. Serum lipids predict cardiac death in diabetic patients on maintenance hemodialysis. Nephrol 1992; 64: 354–358
Koch M, Kutkuhn B, Trenkwalder E, Bach D, Grabensee B, Dieplinger H, Kronenberg F. Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients. J Am Soc Nephrol 1997; 8: 1889–1898
McMillan MA, Briggs JD, Junor BS. Outcome of renal replacement therapy in patients with diabetes mellitus. Bit Med J 1990; 301: 540–544
Yu CC, W MS, W CH, Yang CW, Huang JY, Hong JJ, Chian CYF, Leu ML, Huang CC. Predialysis glycemic control is an independent predictor of clinical outcome in typoe II diabetics on continuous ambulatory peritoneal dialysis. Periton Dial Internat 1997; 17: 262–268
Wu MS, Yu CC, Wang CW, Wu CH, Haung JY, Hong JJ, Fan Chiang CY, Huang CC, Leu ML. Poor predialysis glycemic control is a predictor of mortality in type II diabetic patients on maintenance hemodialysis. Nephrol Dial Transplant 1997; 12:2105-
Foley RN, Parfrey PS. Cardiac disease in the diabetic dialysis patient. Nephrol Dial Transplant (in press)
Fujisawa T, Ikegami H, Shen GG. Angiotensin I converting enzyme polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 1995; 18: 983–985
DeFronzo Ra, Alvestrand A, Smith D, Hendler E, Waren J. Insulin resistance in uremia. J Clin Invest 1981; 67: 563–568
Hörl WH, Haag-Weber M, Georgopoulos A, Block LH. The physicochemical characterization of a novel polypeptide present in uremic serum that inhibits the biological activity of polymorphonuclear cells. Proc Natl Acad Sci 1990; 87: 6353–6357
Zuanetti G, Maggioni AP, Keane W, Ritz E. Nephrologists neglect administration of betablockers to dialysed diabetic patients. Nephrol Dial Transplant 1997; 12: 2497–2501
Weinrauch LA, D’Elia JA, Healy RW. Asymptomatic coronary artery disease angiography in diabetic patients before renal transplantation. Ann Intern Med 1978; 88: 346–348
Manske CL, Thomas W, Wang Y, Wilson RF. Screeding diabetic transplant candidates for coronary artery disease: Identification of a low risk subgroup. Kidney Int 1993; 44: 617–621
Manske CL, Wang Y, Rector T, Wilson RF, White CW. Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet 1992; 340: 998–1002
Rinehart AL, Herzog CA, Collins AJ, Flack JM, Ma JZ, Opsahl JA. Greater risk of cardiac events after coronary angioplasty (PTCA) than bypass grafting (CABG) in chronic dialysis patients. J Am Soc Nephrol 1992; 3: 389(a)
Wizemann V, Kaufinann J, Kramer W. Effect of erythropoietin on ischemia tolerance in anemic hemodialysis patients with confirmed coronary artery disease. Nephron 1992; 62:161–165
Uusitupa M et al. Relationship of blood pressure and left ventricular mass to serum insulin levels in newly diagnosed NIDDM (type II) and in non-diabetic subjects. Diabetes Res 1987; 4:19–25
Ritz E, Rufimann K, Rambausek M, Mall G, Schmidly M Dialysis hypotension — is it related to diastolic left ventricular malfunction? Nephrol Dial Transplant 1987; 2: 193–197
Ringe B, Braun F. Pancreas transplantation: where do we stand in Europe in 1997? Nephrol Dial Transplant 1997; 12: 1100–1104
Rischen-Vos J, van der Woude FJ, Tegzess AM, Zwinderman AH, Gosszen HC, van den Akker PJ, van Es LA. Increased morbidity and mortality in patients with diabetes mellitus after kidney transplantation as compared with non-diabetic patients. Nephrol Dial Transplant 1992; 7: 433–437
Port FK, Wolfe RA, Mauger EA, Berlin DP, Jian K. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA 1993; 270: 1339–1343
Hirschl MM, Derfler K, Heinz G, Sunder-Plassmann G, Waldhäusl W. Longterm follow-up of renal transplantation in type I and type II diabetic patients. Clin Invest 1992; 70:917–921
Borgel F, Benhamou PY, Zmirou D, Balducci F, Halimi S, Cordonnier A. Assessment of handicap in chronic dialysis diabetic patients (Uremidiab Study). Scand J Rehab Med 1992; 24: 203–208
Zmirou D, Benhamou PY, Cordonnier D, Borgel F, Balducci F, Papoz L, Haimi S. Diabetes mellitus prevalence among dialysis patients in France (Uremidiab Study). Nephrol Dial Transplant 1992; 7:1092–1097
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Ritz, E., Raine, A., Cordonnier, D. (1998). Hemodialysis in Type I and Type II Diabetic Patients with Endstage Renal Failure. In: Mogensen, C.E. (eds) The Kidney and Hypertension in Diabetes Mellitus. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6752-0_48
Download citation
DOI: https://doi.org/10.1007/978-1-4757-6752-0_48
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-6754-4
Online ISBN: 978-1-4757-6752-0
eBook Packages: Springer Book Archive